信达生物(01801)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01801 信达生物

未开盘 02-04 16:08:25

80.650

+1.850

+2.35%

最高81.850	最低77.300	成交量925.85万
今开79.200	昨收78.800	日振幅5.77%
总市值1,399亿	流通市值1,399亿	总股本17.35亿
成交额7.39亿	换手率0.53%	流通股本17.35亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01801","market":"HK","secType":"STK","nameCN":"信达生物","latestPrice":80.65,"timestamp":1770192505003,"preClose":78.8,"halted":0,"volume":9258513,"delay":0,"changeRate":0.0234771573604062,"floatShares":1735000000,"shares":1735000000,"eps":-0.06752044873948267,"marketStatus":"未开盘","change":1.85,"latestTime":"02-04 16:08:25","open":79.2,"high":81.85,"low":77.3,"amount":738536233,"amplitude":0.057741,"askPrice":80.65,"askSize":70000,"bidPrice":80.6,"bidSize":24000,"shortable":3,"etf":0,"ttmEps":0.759226933806239,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770255000000},"marketStatusCode":0,"adr":0,"listingDate":1540915200000,"exchange":"SEHK","adjPreClose":78.8,"openAndCloseTimeList":[[1770168600000,1770177600000],[1770181200000,1770192000000]],"volumeRatio":1.0627689748087241,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"INB.HK","impliedVol":0.4626,"impliedVolPercentile":0.1406},"requestUrl":"/m/hq/s/01801","defaultTab":"news","newsList":[{"id":"2608239342","title":"港股公告掘金 | 百胜中国2025年经营利润同比增长11%至13亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608239342","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608239342?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:47","pubTimestamp":1770216425,"startTime":"0","endTime":"0","summary":"重大事项：中通快递-W(02057)拟发售15亿美元的可换股优先票据复星国际(00656)附属复星商发拟以1.05亿元认购商盟科技新增注册资本，对应取得商盟科技增资后51.0879%的股权上海医药(02607)：常州制药厂的西格列汀二甲双胍缓释片获得批准生产中船防务(00317)控股子公司签订16 艘支线集装箱船建造合同翰思艾泰-B(03378)：HX111完成首例病人用药经营业绩：中通快递-W(","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401784.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","BK1583","LU2097828557.USD","LU2097828714.EUR","LU2097828631.EUR","YUMC","LU0128525929.USD","LU2279701549.SGD","LU0431992006.USD","LU0348825331.USD","LU2177674079.SGD","LU2008162690.USD","LU0228659784.USD","LU2488822045.USD","BK1502","LU0029864427.USD","02057","LU1023057109.AUD","LU1267930573.SGD","HK0000306701.USD","HK0000320264.USD","IE00BGV7N243.SGD","LU0594300419.USD","09987","01801","BK4209","LU2097828474.EUR","LU0823426480.USD","BK1233","BK4504","LU2328871848.SGD","BK1575","BK1589","BK4531","LU2097828805.USD","LU2242644610.SGD","LU0455707207.USD","IE00B29SXG58.USD","LU0708994859.HKD","BK1588","LU0823426308.USD","LU0651946864.USD","LU0868486357.SGD","VT","IE00B0JY6N72.USD","LU0502904849.HKD","LU0327786744.USD","LU1051768304.USD","LU0359201612.USD","HK0000165453.HKD"],"gpt_icon":0},{"id":"2608350044","title":"双轮驱动显成效：信达生物2025年收入119亿元同比增45% 肿瘤领域领先地位持续巩固","url":"https://stock-news.laohu8.com/highlight/detail?id=2608350044","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608350044?lang=zh_cn&edition=full","pubTime":"2026-02-04 18:45","pubTimestamp":1770201939,"startTime":"0","endTime":"0","summary":"2月4日，信达生物（01801）发布公告，2025年，公司实现总产品收入约119亿元，同比增长约45%。2025年第四季度，公司实现总产品收入约33亿元，同比增超60%。公告指出，2025年时是公司产品收入首次突破百亿人民币的里程碑之年，标志着本公司“双轮驱动与全球创新”战略的成功落地及卓越成效。公司在肿瘤治疗领域持续巩固领先地位，肿瘤产品组合已拓展至13款，协同效应日益凸显。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602043641552712.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","LU2097828557.USD","LU1969619763.USD","LU2097828805.USD","LU2328871848.SGD","LU0455707207.USD","LU2097828631.EUR","LU2242644610.SGD","BK1589","LU2097828474.EUR","01801","LU2097828714.EUR","HK0000165453.HKD","LU0502904849.HKD","BK1583","LU2488822045.USD"],"gpt_icon":0},{"id":"2608350862","title":"信达生物(01801)2025年实现总产品收入约119亿元 同比保持约45%的强劲增长态势","url":"https://stock-news.laohu8.com/highlight/detail?id=2608350862","media":"智通财经","labels":["dataReport"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608350862?lang=zh_cn&edition=full","pubTime":"2026-02-04 18:26","pubTimestamp":1770200789,"startTime":"0","endTime":"0","summary":"前述情况下，于2025年第四季度，本公司实现总产品收入约人民币33亿元，同比增长超60%以上，依旧延续强劲增长势头。2025年是本公司产品收入首次突破百亿人民币的里程碑之年，标志着本公司“双轮驱动与全球创新”战略的成功落地及卓越成效。2025年的产品业绩表现，再次印证了本公司卓越的商业化运营能力及可持续的业务发展模式。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"信达生物(01801)2025年实现总产品收入约119亿元 同比保持约45%的强劲增长态势","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU2097828714.EUR","HK0000165453.HKD","LU2328871848.SGD","BK1583","LU2242644610.SGD","LU1969619763.USD","LU2097828631.EUR","LU0502904849.HKD","LU2097828557.USD","LU2097828474.EUR","LU2488822045.USD","LU2097828805.USD","01801","LU0455707207.USD","BK1589"],"gpt_icon":0},{"id":"2608827006","title":"摩根大通增持信达生物(01801)约19.89万股 每股作价约83.83港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608827006","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608827006?lang=zh_cn&edition=full","pubTime":"2026-02-03 18:54","pubTimestamp":1770116082,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，1月28日，摩根大通增持信达生物(01801)19.8871万股，每股作价83.829港元，总金额约为1667.12万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260203/20260203185535_91323.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260203/20260203185535_91323.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401141.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"摩根大通增持信达生物(01801)约19.89万股 每股作价约83.83港元","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0820561818.USD","LU1244550221.USD","01801","LU0345769631.USD","IE0034235303.USD","LU0345770308.USD","BK1589","LU0265550359.USD","LU1064131342.USD","IE00BZ1G4Q59.USD","LU0106261372.USD","BK1583","LU1280957306.USD","LU1551013342.USD","LU2213496289.HKD","LU2097828631.EUR","LU0320765646.SGD","IE00BLSP4452.SGD","LU0689472784.USD","LU2756315318.SGD","SG9999002232.USD","LU1668664300.SGD","LU2237443978.SGD","LU0820561909.HKD","LU1363072403.SGD","LU1969619763.USD","LU1116320901.HKD","LU0323591593.USD","LU2054465674.USD","LU1145028129.USD","LU1496350171.SGD","LU0211327993.USD","IE00B775SV38.USD","LU2430703178.SGD","LU1244550577.SGD","BK4504","IE00BJLML261.HKD","BK4566","LU1894683348.USD","LU0251132253.USD","IE00BFXG1179.USD","LU1496350502.SGD","IE00BN8TJ469.HKD","LU1116320737.USD","LU1548497426.USD","LU1551013425.SGD","LU2097828474.EUR","BK4516","LU1032466523.USD","LU0265550946.USD"],"gpt_icon":0},{"id":"2608845876","title":"信达生物02月03日主力净流入2865.1万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2608845876","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608845876?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:16","pubTimestamp":1770106562,"startTime":"0","endTime":"0","summary":"02月03日, 信达生物股价涨0.13%，报收78.80元，成交金额5.4亿元，换手率0.40%，振幅2.86%，量比0.79。信达生物今日主力资金净流入2865.1万元，上一交易日主力净流出659.3万元。该股近5个交易日下跌2.99%，主力资金累计净流入2078.0万元；近20日主力资金累计净流入9042.2万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203162338a6cdaa4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203162338a6cdaa4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1589","LU0455707207.USD","LU1969619763.USD","LU2097828631.EUR","HK0000165453.HKD","LU2328871848.SGD","LU2097828805.USD","LU2097828474.EUR","BK1161","LU2097828714.EUR","LU2242644610.SGD","01801","LU0502904849.HKD","LU2488822045.USD","LU2097828557.USD"],"gpt_icon":0},{"id":"2608481378","title":"每日卖空追踪 | 信达生物 02月02日卖空量成交24.95万股，卖空比例为2.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608481378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608481378?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:30","pubTimestamp":1770021025,"startTime":"0","endTime":"0","summary":"信达生物北京时间02月02日，跌2.96%，卖空量成交24.95万股，较上一交易日减少57.89%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163433a4728bcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163433a4728bcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2097828805.USD","HK0000165453.HKD","LU2097828631.EUR","BK1583","LU2097828474.EUR","LU2488822045.USD","LU1969619763.USD","01801","LU2097828557.USD","LU2328871848.SGD","LU2097828714.EUR","LU2242644610.SGD","BK1589","BK1161","LU0455707207.USD","LU0502904849.HKD"],"gpt_icon":0},{"id":"2608813208","title":"信达生物02月02日遭主力抛售659.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608813208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608813208?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:15","pubTimestamp":1770020145,"startTime":"0","endTime":"0","summary":"02月02日, 信达生物股价跌2.96%，报收78.70元，成交金额6.7亿元，换手率0.49%，振幅4.69%，量比0.99。信达生物今日主力资金净流出659.3万元，连续3日净流出，上一交易日主力净流出1692.9万元。该股近5个交易日下跌3.43%，主力资金累计净流入94.3万元；近20日主力资金累计净流入7602.4万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202162052a4727cfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202162052a4727cfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","LU2097828714.EUR","LU0455707207.USD","LU0502904849.HKD","LU2097828631.EUR","LU2242644610.SGD","LU2097828474.EUR","BK1161","LU1969619763.USD","LU2097828805.USD","LU2488822045.USD","01801","LU2328871848.SGD","BK1583","LU2097828557.USD","BK1589"],"gpt_icon":0},{"id":"2608450810","title":"百济神州 ≈ 信达生物+科伦博泰+康方生物 ？","url":"https://stock-news.laohu8.com/highlight/detail?id=2608450810","media":"医药财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608450810?lang=zh_cn&edition=full","pubTime":"2026-02-02 11:29","pubTimestamp":1770002959,"startTime":"0","endTime":"0","summary":"截止到2026年2月2日午间市值数据显示：百济神州以约3070亿港元的市值，几乎等同于信达生物、科伦博泰生物与康方生物三者的总和。2025年第三季度，百济神州净利润达1.25亿美元，而去年同期为亏损1.21亿美元。信达生物、科伦博泰和康方生物则仍处于高增长、高投入阶段，其估值包含了风险溢价和未来成长潜力。对于信达生物、科伦博泰和康方生物而言，未来18-24个月是关键的验证期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202114914a471920b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202114914a471920b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU1719994722.HKD","LU1770034418.SGD","LU2476274720.SGD","LU2097828631.EUR","09926","LU2097828474.EUR","LU0588546209.SGD","LU0348735423.USD","LU2097828714.EUR","LU0540923850.HKD","IE00BPRC5H50.USD","BK1588","LU0561508036.HKD","LU2399975544.HKD","LU1794554557.SGD","LU0348784397.USD","BK1583","LU0455707207.USD","LU1969619763.USD","LU0348827113.USD","LU2097828805.USD","LU2488822045.USD","LU2242644610.SGD","BK1589","BK1500","BK1161","LU1961090484.USD","LU0634319403.HKD","BK1574","LU1303224171.USD","LU1720050803.USD","LU2097828557.USD","LU2778985437.USD","LU0417516571.SGD","LU0348783233.USD","LU0417516738.SGD","IE00B543WZ88.USD","06160","LU0196878994.USD","LU0348825331.USD","01801","LU0348766576.USD","LU0502904849.HKD","LU0348767384.USD","LU1251922891.USD","LU0417516902.SGD","LU2328871848.SGD","IE00B5MMRT66.SGD","HK0000165453.HKD"],"gpt_icon":0},{"id":"2607025472","title":"AI重塑医药生产力，为何超六成医药企业拥抱钉钉？","url":"https://stock-news.laohu8.com/highlight/detail?id=2607025472","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607025472?lang=zh_cn&edition=full","pubTime":"2026-01-30 09:43","pubTimestamp":1769737380,"startTime":"0","endTime":"0","summary":"以“AI重塑医药生产力”为主题的2026医药钉峰会日前在沪召开，共探人工智能技术如何驱动赋能医药行业。AI自动完成数据抓取、分析与预警，让人人皆可成为开发者，大幅提升了业务响应的敏捷性。此外，AI正成为药企全球化协同的基石。AI不再是遥远的技术概念，而是已经成为医药行业提质、增效、创新的核心驱动要素。随着AI技术产品持续完善、行业生态日益繁荣，一场以人工智能为核心的医药生产力革命，正从蓝图加速照进现实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130095032a466dcda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130095032a466dcda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1366334651.USD","LU0348788117.USD","LU0456846285.SGD","89988","LU1048588211.SGD","LU0708995153.HKD","LU0700851271.USD","LU0254981946.USD","LU1794554557.SGD","LU0328353924.USD","BK1142","LU0499858602.USD","LU1515016050.SGD","LU0577902371.SGD","LU1044876610.USD","LU0164880469.USD","LU0791590937.USD","BK1161","LU0327786744.USD","LU1568876335.HKD","LU0127658192.USD","LU0455707207.USD","SG9999002828.SGD","LU1282649810.SGD","LU0261947096.USD","LU1282649141.HKD","LU0449509016.USD","SG9999001093.SGD","LU0605514214.HKD","LU1770036033.HKD","LU0264606111.USD","LU1323998911.USD","LU0594300179.USD","BK1615","LU0128522157.USD","LU0214875030.USD","LU1328277881.USD","LU0784639295.USD","LU0106959298.USD","LU1366334578.USD","LU1720051108.HKD","LU2097828474.EUR","SG9999000327.SGD","LU1188198961.HKD","LU0898667661.SGD","LU0326950275.SGD","LU0348783662.USD","LU0543330483.HKD","IE00B3M56506.USD","BK1588","BK1618","HK0000320223.HKD","SG9999001051.SGD","LU0348783233.USD","LU0417516571.SGD","LU0048597586.USD","LU2152927971.USD","LU1961090484.USD","LU0251144936.SGD","LU0417516902.SGD","LU2257852520.SGD","LU2449936058.SGD","LU0261950983.USD","BK1586","SG9999002463.SGD","SG9999014674.SGD","HK0000306685.HKD","LU1719994722.HKD","BK1608","IE00BZ08YS42.EUR","LU1769817179.HKD","LU0314109678.HKD","LU0588545490.SGD","LU1242518857.USD","LU0117841782.USD","LU0823040885.USD","LU1251922891.USD","LU2125910849.SGD","LU1568876251.USD","LU0640798160.USD","LU0011963245.USD","LU0307460666.USD","LU0708995583.HKD","02607","IE0008368304.USD","IE00B5MMRT66.SGD","BK1517","LU0890818403.SGD","LU0228367735.SGD","LU0819121731.USD","LU1769817096.USD","BK1521","LU1224444064.USD","LU0531970944.HKD","LU0762542818.HKD","LU0370786039.SGD","LU0979878070.USD","LU2242644610.SGD","LU1807302812.USD","06127","LU1211504680.USD","000538","LU0871576103.HKD","LU0862451753.SGD","LU0594300419.USD","LU0572940350.SGD","LU0516423174.USD","LU0130103400.USD","LU0675040207.SGD","LU0577902538.SGD","LU1316542783.SGD","LU0611395673.USD","LU0132412106.USD","LU0672654166.SGD","LU0348825331.USD","LU0047713382.USD","LU1048484197.HKD","LU1808992512.USD","LU0862451837.USD","LU0210527791.USD","LU0823426308.USD","LU0287142896.SGD","LU1504937902.USD","LU1831875114.USD","LU0516423091.SGD","SG9999001226.SGD","LU1956131251.USD","LU0737861699.HKD","LU1201861165.SGD","LU0197773160.USD","LU0096374516.USD","600276","LU0762541174.USD","IE00BMPRXR70.SGD","LU1770034418.SGD","BK1249","LU2045819591.USD","LU1224709979.USD","LU1868837565.USD","LU0642271901.SGD","SG9999006514.SGD","LU0823413660.USD","LU0106252389.USD","LU0572944931.SGD","LU0828237510.HKD","LU0651947912.USD","LU0048580855.USD","LU0831103253.SGD","LU1981816686.USD","LU0868486357.SGD","LU0831093199.SGD","LU0572939691.SGD","LU0384037296.USD","BK1584","LU0823397285.USD","LU1720051017.SGD","SG9999000459.SGD","LU0164865239.USD","LU0456827905.SGD","LU1044875133.USD","LU1328615791.USD","LU0608807433.USD","LU1548497426.USD","603127","LU0052750758.USD","LU0329678337.USD","LU0823039010.USD","01801","LU1880383440.USD","LU0762540952.USD","LU0396098781.USD","LU0072462343.USD","LU0531971595.HKD","IE00B543WZ88.USD","LU0417516738.SGD","LU0607220059.USD","LU0043850808.USD","SG9999004220.SGD","BK1583","LU0431992006.USD","IE00BMPRXN33.USD","LU1810669033.SGD","LU0348784397.USD","BK1574","LU0149534421.HKD","LU1023057109.AUD","BK1610","LU0210526637.USD","LU0463099449.HKD","LU0488056044.USD","LU1969619763.USD","LU0348735423.USD","LU0737861772.HKD","LU0477156797.USD","BK1515","SHPMY","LU0821914370.USD","LU0516422440.USD","09988","LU0516422952.EUR","IE00BPRC5H50.USD","LU0211977185.USD","LU1242518931.SGD","IE00B0169N27.USD","LU0823038988.USD","LU0819123356.HKD","LU0593848301.USD","LU0865486749.SGD","LU0441854154.USD","LU0169518387.USD","LU2097828805.USD","LU0315179316.USD","LU0049853897.USD","LU0228659784.USD","LU1048596156.SGD","02157","LU0039217434.USD","LU0320764755.SGD","HK0000320264.USD","LU1868838027.USD","LU0029874905.USD","LU0499858438.USD","LU0791591158.USD","LU2087589342.USD","LU0588545904.SGD","LU0164872284.USD","SG9999001689.USD","IE00B0JY6N72.USD","IE0032431581.USD","LU0588546209.SGD","LU2357305700.SGD","SG9999002562.SGD","LU0856984785.SGD","LU0048388663.USD","LU0540923850.HKD","LU1993786604.SGD","LU2399975544.HKD","LU0128522744.USD","LU0165289439.USD","HK0000306701.USD","LU1044874839.SGD","LU0577902454.USD","LU0140636845.USD","LU1303224171.USD","LU0320764599.SGD","LU1282649067.USD","LU0084288322.USD","LU2293587155.HKD","LU0823397103.USD","LU0634319403.HKD","LU1688375341.USD","LU0886674414.USD","LU1282651121.HKD","LU2488822045.USD","LU0823413587.USD","LU0315178854.USD","LU0588545730.USD","LU0231483743.USD","LU0516422366.SGD","LU0244354667.USD","LU1813983027.USD","LU0648948544.HKD","LU1720050803.USD","LU2097828631.EUR","LU2476274308.USD","LU0359201612.USD","LU0181495838.USD","BK1591","LU0577902611.USD","LU0502904849.HKD","LU1880398554.USD","LU3063872942.SGD","LU0143863198.USD","LU1642822792.SGD","LU1439103000.SGD","LU1051768304.USD","LU0173614495.USD","LU2476274720.SGD","LU0469268626.HKD","LU0541502299.USD","BK1501","LU0106259558.USD","LU0293314216.USD","LU0029875118.USD","LU0828237940.HKD","601607","LU0648000940.SGD","LU0235996351.USD","01276","LU0359202008.SGD","HK0000165453.HKD","LU0061477393.USD","LU0630378429.USD","LU1196710864.SGD","IE00BZ08YR35.GBP","LU0051755006.USD","LU0130518102.USD","LU0149721374.USD","LU0608807946.USD","LU0054237671.USD","LU0348827113.USD","LU0543330566.HKD","LU1655091459.SGD","LU0359201885.HKD","LU0329678170.USD","LU0259732245.USD","LU2097829019.USD","BK1589","LU0196878994.USD","LU0561508036.HKD","SG9999006597.SGD","LU2328871848.SGD","LU2097828714.EUR","BK1502","LU0117844026.USD","IE0003895053.USD","LU2097828557.USD","LU1115378108.SGD","IE0034224299.USD","LU0229945570.USD","LU2778985437.USD","LU0320764243.SGD","LU0651946864.USD","BK1575","LU0143863784.USD","LU1880398471.USD","LU1880383366.USD","LU1960683339.HKD","LU2039709279.SGD","LU2125910500.SGD","LU0345775950.USD","SGXZ90724238.SGD","LU0589944569.HKD","LU0650527681.SGD","LU0197773673.USD","LU0449515922.USD","LU1282651048.USD","BABA","LU0873338254.USD","LU0823426480.USD","LU0823041008.USD","LU1051769294.HKD","ALBmain","LU1481107354.HKD","IE00BZ08YT58.USD","LU0163747925.USD","HBBD.SI","LU0630378692.HKD","LU0348805143.USD","LU0345776255.USD","LU0577902298.EUR","LU0541501648.USD","LU0054450605.USD","SG9999001903.USD"],"gpt_icon":1},{"id":"2607704090","title":"每日卖空追踪 | 信达生物 01月29日卖空量成交21.3万股，卖空比例为2.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607704090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607704090?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:30","pubTimestamp":1769675426,"startTime":"0","endTime":"0","summary":"信达生物北京时间01月29日，跌2.42%，卖空量成交21.3万股，较上一交易日减少78.55%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129163838a6bae132&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129163838a6bae132&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2097828474.EUR","LU2097828714.EUR","LU2328871848.SGD","BK1583","LU2242644610.SGD","HK0000165453.HKD","LU0455707207.USD","BK1589","BK1161","LU2097828631.EUR","LU1969619763.USD","LU2097828557.USD","LU2097828805.USD","LU2488822045.USD","LU0502904849.HKD","01801"],"gpt_icon":0},{"id":"2607704774","title":"信达生物01月29日主力净流出1472.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2607704774","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607704774?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:15","pubTimestamp":1769674545,"startTime":"0","endTime":"0","summary":"01月29日, 信达生物股价跌2.42%，报收82.50元，成交金额6.9亿元，换手率0.48%，振幅2.07%，量比0.84。信达生物今日主力资金净流出1472.3万元，上一交易日主力净流入3037.4万元。该股近5个交易日上涨2.03%，主力资金累计净流出5858.6万元；近20日主力资金累计净流入1.3亿元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129162056a6bacdb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129162056a6bacdb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","LU2097828805.USD","BK1161","LU2488822045.USD","LU2328871848.SGD","LU2242644610.SGD","BK1583","LU0455707207.USD","LU2097828474.EUR","01801","LU0502904849.HKD","LU2097828557.USD","LU2097828631.EUR","BK1589","LU1969619763.USD","LU2097828714.EUR"],"gpt_icon":0},{"id":"2607704071","title":"信达生物：双抗双毒素ADC新药获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2607704071","media":"求实药社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607704071?lang=zh_cn&edition=full","pubTime":"2026-01-29 12:01","pubTimestamp":1769659279,"startTime":"0","endTime":"0","summary":"来源：药研网1月29日，CDE官网公示，信达生物一类新药IBI3028的临床试验申请获得批准，用于标准治疗失败的局部晚期、不可切除或转移性实体瘤。据公开资料显示，IBI3028是一款双抗双毒素抗体偶联药物。IBI3028基于信达生物自主研发的DuettX 双载荷 ADC 平台构建，创新性地将双特异性抗体与两种作用机制不同的细胞毒性载荷相结合。目前，IBI3028的具体靶点组合及毒素类型尚未完全披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129124216953ed9f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129124216953ed9f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","LU2097828631.EUR","BK1589","LU2242644610.SGD","LU2097828474.EUR","BK1583","LU0455707207.USD","LU2097828805.USD","LU0502904849.HKD","LU2328871848.SGD","LU1969619763.USD","LU2097828557.USD","HK0000165453.HKD","01801","BK1161","LU2097828714.EUR"],"gpt_icon":0},{"id":"2606479639","title":"信达生物01月28日获主力加仓3037.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606479639","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606479639?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:15","pubTimestamp":1769588131,"startTime":"0","endTime":"0","summary":"01月28日, 信达生物股价涨3.30%，报收84.55元，成交金额9.7亿元，换手率0.67%，振幅3.24%，量比1.21。信达生物今日主力资金净流入3037.4万元，上一交易日主力净流入881.4万元。|01月28日主力加仓幅度排名||#|股票简称|主力净额占比|#|中国新消费集团|6.04%|#|曼妠|4.88%|#|GBA集团|2.92%|#|...|...|#362|信达生物|0.02%|（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128161859a45f7003&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128161859a45f7003&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","LU2097828805.USD","LU2242644610.SGD","BK1583","LU2097828714.EUR","BK1161","HK0000165453.HKD","BK1589","01801","LU0502904849.HKD","LU2097828557.USD","LU1969619763.USD","LU2488822045.USD","LU2097828474.EUR","LU2097828631.EUR","LU0455707207.USD"],"gpt_icon":0},{"id":"2606768580","title":"港股异动 | 信达生物(01801)涨近3% IBI3003获美国FDA快速通道资格认定 治疗多发性骨髓瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2606768580","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606768580?lang=zh_cn&edition=full","pubTime":"2026-01-28 10:12","pubTimestamp":1769566325,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，信达生物涨近3%，截至发稿，涨2.2%，报83.6港元，成交额2.04亿港元。消息面上，据信达生物官微消息，2026年1月27日，公司宣布其抗GPRC5D/BCMA/CD3三特异性抗体IBI3003获得美国食品和药物监督管理局授予快速通道资格，拟定适应症为接受过含一种蛋白酶体抑制剂、一种免疫调节药物及一种抗CD38单抗的至少四线治疗的复发或难治性多发性骨髓瘤。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398348.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 信达生物(01801)涨近3% IBI3003获美国FDA快速通道资格认定 治疗多发性骨髓瘤","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU2097828714.EUR","HK0000165453.HKD","LU2328871848.SGD","BK1583","LU2242644610.SGD","LU1969619763.USD","LU2097828631.EUR","LU0502904849.HKD","LU2097828557.USD","LU2097828474.EUR","LU2488822045.USD","LU2097828805.USD","01801","LU0455707207.USD","BK1589"],"gpt_icon":0},{"id":"2606873255","title":"每日卖空追踪 | 信达生物 01月27日卖空量成交15.9万股，卖空比例为2.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606873255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606873255?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:30","pubTimestamp":1769502626,"startTime":"0","endTime":"0","summary":"信达生物北京时间01月27日，涨0.24%，卖空量成交15.9万股，较上一交易日减少83.25%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127163924a6b235e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127163924a6b235e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0455707207.USD","LU2097828557.USD","LU2097828631.EUR","01801","LU2488822045.USD","LU2097828805.USD","LU0502904849.HKD","LU2097828714.EUR","BK1583","HK0000165453.HKD","BK1161","LU2097828474.EUR","BK1589","LU1969619763.USD","LU2328871848.SGD","LU2242644610.SGD"],"gpt_icon":0},{"id":"2606732552","title":"信达生物01月27日主力净流入881.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2606732552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606732552?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:15","pubTimestamp":1769501714,"startTime":"0","endTime":"0","summary":"01月27日, 信达生物股价涨0.24%，报收81.85元，成交金额5.5亿元，换手率0.39%，振幅2.57%，量比0.67。信达生物今日主力资金净流入881.4万元，上一交易日主力净流出838.0万元。该股近5个交易日下跌0.84%，主力资金累计净流出1.5亿元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入5343.7万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127161606a45b230e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127161606a45b230e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0502904849.HKD","LU2097828474.EUR","LU2097828557.USD","HK0000165453.HKD","01801","BK1161","BK1589","LU0455707207.USD","LU2097828631.EUR","LU2097828714.EUR","LU2097828805.USD","LU2328871848.SGD","LU2488822045.USD","LU2242644610.SGD","BK1583","LU1969619763.USD"],"gpt_icon":0},{"id":"2606206727","title":"2025年中国创新药对外授权交易额超1300亿美元创纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=2606206727","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606206727?lang=zh_cn&edition=full","pubTime":"2026-01-27 15:31","pubTimestamp":1769499062,"startTime":"0","endTime":"0","summary":"2025年，中国创新药对外授权交易总金额超过1300亿美元，交易数量逾150笔，占全球总量约40%，创下历史新高。阿斯利康在2025年3月初宣布25亿美元投资计划，涵盖三项BD交易及一笔收购。辉瑞与三生制药于2025年5月达成的交易刷新中国创新药出海首付款纪录，达12.5亿美元；礼来全部4笔交易均为技术平台合作，其中2笔涉及晶泰控股与英硅智能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127153959a6b1f6d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127153959a6b1f6d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","BK1574","01276","01801","01093","01530","03696","BK1161","02509","02142","03692"],"gpt_icon":0},{"id":"2606272282","title":"华福证券：医药生物业新技术全面突破 战略看多中国创新出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2606272282","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606272282?lang=zh_cn&edition=full","pubTime":"2026-01-27 11:01","pubTimestamp":1769482871,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华福证券发布研报称，2025年中国创新药全球竞争力凸显，出海交易创新高，多家企业扭亏为盈。战略看多中国创新出海。华福证券主要观点如下：国内复盘：全球竞争力凸显，企业扭亏为盈+管线出海价值新高度2025创新药指数大涨，Biopharma和Biotech持仓比例显著提升，核心驱动因素是中国创新药全球竞争力凸显。创新药市场份额快速提升，肿瘤与免疫领域创新药份额超32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127110355a6b10694&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127110355a6b10694&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","01801","HK0000165453.HKD","09606","06160","BK1583","09887","01276","BK1574","06955","09926","06938","BK1161","06978","02157","02162","01530","02615","02096","BK1593","01093"],"gpt_icon":0},{"id":"1175967548","title":"信达生物宣布Ibi3003（Gprc5d/Bcma/Cd3三特异性抗体）获美国FDA授予针对复发或难治性多发性骨髓瘤的快速通道资格","url":"https://stock-news.laohu8.com/highlight/detail?id=1175967548","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175967548?lang=zh_cn&edition=full","pubTime":"2026-01-27 08:02","pubTimestamp":1769472131,"startTime":"0","endTime":"0","summary":"信达生物宣布，其研发的Ibi3003（一种靶向Gprc5d/Bcma/Cd3的三特异性抗体）已获得美国食品药品监督管理局（FDA）授予的快速通道资格，用于治疗复发或难治性多发性骨髓瘤。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2328871848.SGD","LU2097828805.USD","LU2242644610.SGD","BK1583","LU2097828714.EUR","BK1161","HK0000165453.HKD","BK1589","01801","LU0502904849.HKD","LU2097828557.USD","LU1969619763.USD","LU2488822045.USD","LU2097828474.EUR","LU2097828631.EUR","LU0455707207.USD"],"gpt_icon":0},{"id":"2606758216","title":"2025第十一届中国最具影响力医药企业百强榜发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2606758216","media":"江南时报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606758216?lang=zh_cn&edition=full","pubTime":"2026-01-26 17:16","pubTimestamp":1769418960,"startTime":"0","endTime":"0","summary":"2026年1月26日，由董事会网、亚布力智库联合主办的“2025第十一届中国最具影响力医药企业百强榜”正式揭晓。在医药产业从“规模扩张”向“创新驱动”转型的关键期，本届百强榜的发布具有多重行业价值，成为解读中国医药产业格局的重要窗口。从本届榜单不难看出，中国医药产业正呈现“创新集聚、分化加剧、区域协同”的发展趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126172516a456f932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126172516a456f932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00460","06821","00874","BK1161","01530","09939","01477","02315","BK1574","01801","06160","BK1191","02196","BK1515","03692","01276","02607","02615"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.innoventbio.com","stockEarnings":[{"period":"1week","weight":-0.0461},{"period":"1month","weight":-0.0353},{"period":"3month","weight":-0.0866},{"period":"6month","weight":-0.1162},{"period":"1year","weight":1.4329},{"period":"ytd","weight":0.0577}],"compareEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":0.019},{"period":"3month","weight":0.0136},{"period":"6month","weight":0.08},{"period":"1year","weight":0.2914},{"period":"ytd","weight":0.0475}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"信达生物制药是一家主要从事研发、生产及销售治疗肿瘤、心血管及代谢（CVM）、自身免疫及眼科等重大疾病创新药物的投资控股公司。药物形式包括单克隆抗体、多特异性抗体、免疫细胞因子、抗体偶联药物（ADC）、细胞治疗及小分子药物等。该公司的主要产品包括达伯舒（信迪利单抗注射液）、达攸同（贝伐珠单抗注射液）、苏立信（阿达木单抗注射液）、达伯华（利妥昔单抗注射液）、达伯坦（佩米替尼片）等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.041076},{"month":2,"riseRate":0.625,"avgChangeRate":0.103667},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.021767},{"month":4,"riseRate":0.714286,"avgChangeRate":0.040816},{"month":5,"riseRate":0.428571,"avgChangeRate":0.027398},{"month":6,"riseRate":0.714286,"avgChangeRate":0.139165},{"month":7,"riseRate":0.428571,"avgChangeRate":0.010056},{"month":8,"riseRate":0.714286,"avgChangeRate":0.000214},{"month":9,"riseRate":0.571429,"avgChangeRate":0.032182},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.02286},{"month":11,"riseRate":0.625,"avgChangeRate":0.079172},{"month":12,"riseRate":0.375,"avgChangeRate":0.024026}],"exchange":"SEHK","name":"信达生物","nameEN":"INNOVENT BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"信达生物(01801)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供信达生物(01801)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"信达生物,01801,信达生物股票,信达生物股票老虎,信达生物股票老虎国际,信达生物行情,信达生物股票行情,信达生物股价,信达生物股市,信达生物股票价格,信达生物股票交易,信达生物股票购买,信达生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"信达生物(01801)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供信达生物(01801)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}